0.228
Cosmos Health Inc stock is traded at $0.228, with a volume of 2.12M.
It is down -6.88% in the last 24 hours and up +4.87% over the past month.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
See More
Previous Close:
$0.2428
Open:
$0.25
24h Volume:
2.12M
Relative Volume:
0.23
Market Cap:
$22.94M
Revenue:
$69.49M
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.3513
EPS:
-0.649
Net Cash Flow:
$-14.46M
1W Performance:
+10.08%
1M Performance:
+4.87%
6M Performance:
-42.51%
1Y Performance:
-71.38%
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
COSM
Cosmos Health Inc
|
0.228 | 21.39M | 69.49M | -21.13M | -14.46M | -0.649 |
|
MCK
Mckesson Corp
|
907.18 | 97.79B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
331.20 | 60.05B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
239.37 | 53.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
88.54 | 9.86B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
0.90 | 873.84M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health C-Sept PRO sales exceed $1.3 million at 72% margin - scanx.trade
Is Cosmos Health Inc (COSM) Undervalued After Q2 Earnings Miss? GF Score: 29/100, Revenue at $18.99 Million - GuruFocus
Cosmos Reports Record Q2: Revenue $19.0M, H1 $36.9M; Adjusted Gross Profit Up 58% - TradingView
Cosmos Health Company Profile & Introduction - Moomoo
COSM Looks 40.0% Undervalued on GF Value™ Amid Distribution Deal - GuruFocus
Cosmos Health signs exclusive Saudi distribution deal for supplements By Investing.com - Investing.com South Africa
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare - TradingView
Cosmos Health signs exclusive Saudi distribution deal for supplements - Investing.com
Cosmos Health Secures Exclusive Saudi Arabia Distribution Agreement for Sky Premium Life with Innova Healthcare - Quiver Quantitative
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term - NTB Kommunikasjon
COSM Looks 43.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
MSN Money - MSN
Cosmos (COSM) Latest Quarter: The EPS Result Is Below Expectation in the Reported Period; Closing Reaction: The Stock Loses 6.20% in the Current UpdateAdjusted Earnings Analysis - Vinanet
Cosmos Health reports record Q2 revenue of $19 million By Investing.com - Investing.com Nigeria
Cosmos Health reports record Q2 revenue of $19 million, up 29% - Investing.com Nigeria
Cosmos Health Q2 Results: EPS Misses Estimate, Sales Rise 29% YoY - scanx.trade
Cosmos Health Reports Q2 2026 - TradingView
Cosmos Health Reports Record Q2 and First-Half 2026 Revenue, Exceeds $75 Million Adjusted Annualized Run-Rate - Quiver Quantitative
BRIEF-Cosmos Health Q2 Gross Profit USD 1.51 Million - TradingView
Press Release: Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Progra - Moomoo
Cosmos Health Q2 Net Loss Widens to $5.4M on Revenue Decline - Minichart
Cosmos Health Inc. (COSM) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Cosmos Health Inc. 2026: Revenue $18.99M, EPS ($0.1) — 10-Q Summary - TradingView
Cosmos Health (NASDAQ: COSM) grows revenue yet flags doubt about its future - Stock Titan
Cosmos Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Cosmos Health(COSM) Stock Options Chain | Quotes & News - Moomoo
Cosmos Health Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Cosmos Health Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Price to earnings forward of Cosmos Health Inc – DUS:V67A - TradingView
Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cosmos Health (NASDAQ: COSM) CEO swaps $70K debt for 349,825 shares - Stock Titan
Form 4 Cosmos Health Inc. For: 30 July By Investing.com - Investing.com Canada
Cosmos Health Inc. (COSM) CFO swaps $60,000 debt for company stock - Stock Titan
Cosmos Health (NASDAQ: COSM) CEO swaps $140,000 debt for 766,284 new shares - Stock Titan
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels - The Manila Times
Cosmos Health Advances its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C And B2B Channels - marketscreener.com
Cosmos Health Advances Its Technology-Driven Transformation - GlobeNewswire
Cosmos Health develops subscription platform for health products By Investing.com - Investing.com Canada
Cosmos Health develops subscription platform for health products - Investing.com
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health Inc (COSM) Cash Flow - TradingKey
Cosmos Health Inc (COSM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cosmos Health Inc (COSM) Income Statement - tradingkey.com
COSM|Cosmos Health Inc|Price:0.205|Chg%:+0.005 - TradingKey
Cosmos Health Inc (COSM) Institutional Confidence - TradingKey
Cosmos Health Inc (COSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cosmos Health Inc (COSM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cosmos Health Inc (COSM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Daily Brief Health Care: Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Akeso, Mitesco Inc, Nagaileben, Repligen Corp, Scribe Therapeutics, Cosmos Health and more - Smartkarma
COSM|Cosmos Health Inc|Price:0.199|Chg%:-0.001 - TradingKey
Cosmos Health Inc (COSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cosmos Health Inc Stock (COSM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jul 29 '26 |
Buy |
0.18 |
766,284 |
140,000 |
14,248,092 |
| Terzis Georgios | Chief Financial Officer |
Jun 16 '26 |
Buy |
0.25 |
168,135 |
42,000 |
2,235,398 |
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):